You are here
- Home
- Therapy Areas
Respiratory/Inflammation
The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials. For more information on both of these therapy areas please click here.
- collapse A randomized, multicenter, placebo and active-controlled, single-dose, 4-period, crossover study to evaluate the bronchodilating effect of SYMBICORT pMDI versus Advair Diskus and Ventolin HFA.
- collapse A randomized, multicenter, placebo and active-controlled, single-dose, 4-period, crossover study to evaluate the bronchodilating effect of SYMBICORT pMDI versus Advair Diskus and Ventolin HFA.
- collapse A randomized, multicenter, open-label, active-controlled, single-dose, 5-period, incomplete block, cross-over study to evaluate the relative bronchodilating effects of formoterol when administered via Symbicort pMDI or Oxis Turbuhaler to adults with stable asthma.
- collapse Management of patients with moderate to severe asthma uncontrolled when treated with low dose inhaled corticosteroids: Cost-effectiveness of three therapeutics alternatives.
- collapse Prevention of Asthma in infants/young children
- collapse Cross-sectional, observational Real Life study on NSAIDs treated patients with Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondilitis: Assessment of patient adherence to PPI treatment
- collapse A Retrospective Epidemiological Study to map out patients with Chronic Obstructive Pulmonary Disease (COPD) and Describe COPD health care in Real-Life Primary Care during the first ten years of the 21th century.
- collapse A phase II, randomised, double-blind, placebo-controlled, parallel group study to assess the efficacy of 28 day oral administration of AZD9668 in patients with bronchiectasis
- collapse Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand
- collapse Observational study to evaluate the correctness of the use of inhaler device in patients with asthma or chronic obstruct
